Group One Trading
ZVRA icon

Group One Trading’s Zevra Therapeutics ZVRA Stock Holding History

Group One Trading’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-52,638
Closed -$498K – 9331
2025
Q3 		$501K Buy
+52,638
New +$528K ﹤0.01% 3703
2024
Q3 		– Sell
-28,272
Closed -$192K – 7485
2024
Q2 		$139K Buy
28,272
+11,308
+67% +$53.6K ﹤0.01% 3695
2024
Q1 		$98.4K Sell
16,964
-22,664
-57% -$139K ﹤0.01% 4174
2023
Q4 		$260K Buy
39,628
+3,729
+10% +$17.4K ﹤0.01% 3626
2023
Q3 		$173K Sell
35,899
-11,196
-24% -$55.9K ﹤0.01% 3926
2023
Q2 		$240K Sell
47,095
-2,834
-6% -$15.3K ﹤0.01% 3749
2023
Q1 		$275K Sell
49,929
-26,068
-34% -$138K ﹤0.01% 3372
2022
Q4 		$349K Buy
+75,997
New +$386K ﹤0.01% 3364
2021
Q2 		– Sell
-13,163
Closed -$141K – 8645
2021
Q1 		$121K Buy
+13,163
New +$115K ﹤0.01% 5485
2020
Q2 		– Sell
-1,906
Closed -$7K – 6256
2020
Q1 		$7K Buy
1,906
+1,875
+6,048% +$10.4K ﹤0.01% 4692
2019
Q4 		$0 Hold
31
– – ﹤0.01% 5705
2019
Q3 		$0 Hold
31
– – ﹤0.01% 5628
2019
Q2 		$1K Hold
31
– – ﹤0.01% 4846
2019
Q1 		$1K Hold
31
– – ﹤0.01% 4678
2018
Q4 		$1K Sell
31
-399
-93% -$16.1K ﹤0.01% 4756
2018
Q3 		$33K Buy
+430
New +$33.6K ﹤0.01% 4199

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading's ZVRA Position: Q4 2025 in Review

Group One Trading sold out of Zevra Therapeutics (ZVRA) in Q4 2025, closing a stake of 52,638 shares — an estimated $498K sold.

Group One Trading first reported a position in ZVRA in Q3 2018 and held it in 16 quarters. The position peaked at $501K in Q3 2025. 158 funds tracked by Wall St. Rank hold ZVRA as of Q4 2025.

  • Group One Trading reported no remaining Zevra Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 52,638 Zevra Therapeutics shares in Q4 2025, an estimated $498K.
  • Group One Trading first reported a position in Zevra Therapeutics in Q3 2018 and held it in 16 quarters.
  • Group One Trading's Zevra Therapeutics position peaked at $501K in Q3 2025.
  • 158 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.